Company news
Hua Medicine Ltd. news in 2021
Hua Medicine Ltd.'s news releases, calls and decks from 2021, newest first.
Hua Medicine Announces 2020 Interim Results
August 19, 2021
Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally
April 23, 2021
Voluntary announcement - new drug application for dorzagliatin accepted in china by the national medical products administration
April 23, 2021
Milestone Development Achieved in Clinical Trials and Commercialization, Hua Medicine's Dorzagliatin Readying for NDA Submission
March 19, 2021